welbournes

/welbournes

About welbournes

This author has not yet filled in any details.
So far welbournes has created 446 blog entries.

Medicine Supply Notification: Torasemide 10mg tablets

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Torasemide 10mg tablets MSN/2024/098 Tier 2 – medium impact Date of issue: 2nd October 2024 Torasemide 10mg tablets are in limited supply until March 2025. Torasemide 5mg tablets remain available and can support a partial increase in demand. Alternative loop diuretics [...]

The post Medicine Supply Notification: Torasemide 10mg tablets appeared first on Community Pharmacy England.

By |October 2nd, 2024|Lexpos News|Comments Off on Medicine Supply Notification: Torasemide 10mg tablets

Rolled over price concessions for October 2024

The following price concessions granted in September 2024 have rolled over to October 2024: Drug Pack size Price concession Carbimazole 5mg tablets 100 £1.98 Hydroxocobalamin 1mg/1ml solution for injection ampoules 5 £11.75 Propantheline bromide 15mg tablets 112 £103.50 Please note any rolled over prices can be adjusted upwards if we receive reports from pharmacy owners [...]

The post Rolled over price concessions for October 2024 appeared first on Community Pharmacy England.

By |October 1st, 2024|Lexpos News|Comments Off on Rolled over price concessions for October 2024

September 2024 Price Concessions Final Update

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (01/10/2024) announced the following final list of price concessions for September 2024: Drug Pack size Price concession Amantadine 100mg capsules 56 £18.06 Apixaban 2.5mg tablets 60 £14.99 Apixaban [...]

The post September 2024 Price Concessions Final Update appeared first on Community Pharmacy England.

By |October 1st, 2024|Lexpos News|Comments Off on September 2024 Price Concessions Final Update

MHRA Class 4 Medicines Defect Information: Risperidone 1mg, 2mg, 3mg tablets (Sandoz Ltd)

MHRA Class 4 Medicines Defect Information: Risperidone 1mg, 2mg, 3mg tablets (Sandoz Ltd) Drug alert number: EL (24)A/43 Date issued: 26 September 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Risperidone 1mg, 2mg, 3mg tablets (Sandoz Ltd) Company name: Sandoz Ltd Product name: Risperidone 1mg [...]

The post MHRA Class 4 Medicines Defect Information: Risperidone 1mg, 2mg, 3mg tablets (Sandoz Ltd) appeared first on Community Pharmacy England.

By |September 26th, 2024|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Information: Risperidone 1mg, 2mg, 3mg tablets (Sandoz Ltd)

DHSC publishes consultation response on changes to Part IX of the Drug Tariff

On 28th August 2024, the Department of Health and Social Care (DHSC) published its response to the targeted consultation: ‘Medical Devices in Primary Care: Proposals for updating Part IX of the Drug Tariff‘. Part IX of the The Drug Tariff contains the appliances and chemical reagents, which can be prescribed by prescribing practitioners in primary care operating under NHS General Medical [...]

The post DHSC publishes consultation response on changes to Part IX of the Drug Tariff appeared first on Community Pharmacy England.

By |September 25th, 2024|Lexpos News|Comments Off on DHSC publishes consultation response on changes to Part IX of the Drug Tariff